Supernus Pharmaceuticals マネジメント
マネジメント 基準チェック /24
Supernus Pharmaceuticalsの CEO はJack Khattarで、 Jan2005年に任命され、 の在任期間は 19.83年です。 の年間総報酬は$ 13.28Mで、 7.3%給与と92.7%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の3.53%を直接所有しており、その価値は$ 70.38M 。経営陣と取締役会の平均在任期間はそれぞれ9.6年と12.3年です。
主要情報
Jack Khattar
最高経営責任者
US$13.3m
報酬総額
CEO給与比率 | 7.3% |
CEO在任期間 | 19.8yrs |
CEOの所有権 | 3.5% |
経営陣の平均在職期間 | 9.6yrs |
取締役会の平均在任期間 | 12.3yrs |
経営陣の近況
Recent updates
Supernus Pharmaceuticals: Recently Launched Qelbree Is Powering Growth
Nov 12Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Share Price Could Signal Some Risk
Oct 31Supernus: Stock Slides As Qelbree Sales Questioned, But Positives Still Outweigh Negatives
Sep 12Supernus Pharmaceuticals' (NASDAQ:SUPN) Conservative Accounting Might Explain Soft Earnings
Aug 19Supernus Pharmaceuticals: So-So Neuroscience Portfolio, With ADHD Standout
Jul 02Subdued Growth No Barrier To Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Price
Apr 24Supernus Pharmaceuticals: Moving Through An 'Inflection Year'
Mar 04We Think Supernus Pharmaceuticals (NASDAQ:SUPN) Can Stay On Top Of Its Debt
May 10Does Supernus Pharmaceuticals (NASDAQ:SUPN) Have A Healthy Balance Sheet?
Feb 03These 4 Measures Indicate That Supernus Pharmaceuticals (NASDAQ:SUPN) Is Using Debt Reasonably Well
Oct 19Supernus stock falls 12.6% after FDA declines to approve Parkinson’s disease treatment
Oct 10Supernus Pharmaceuticals: Deep Expertise In CNS, Eyes On Qelbree Launch And Parkinson Portfolio
Aug 19Supernus Pharmaceuticals' (NASDAQ:SUPN) Soft Earnings Are Actually Better Than They Appear
Aug 16Supernus: A Work In Progress
Jul 29Supernus: New Beginnings
Mar 28CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$60m |
Jun 30 2024 | n/a | n/a | US$5m |
Mar 31 2024 | n/a | n/a | -US$16m |
Dec 31 2023 | US$13m | US$963k | US$1m |
Sep 30 2023 | n/a | n/a | US$26m |
Jun 30 2023 | n/a | n/a | US$43m |
Mar 31 2023 | n/a | n/a | US$52m |
Dec 31 2022 | US$10m | US$914k | US$61m |
Sep 30 2022 | n/a | n/a | US$38m |
Jun 30 2022 | n/a | n/a | US$57m |
Mar 31 2022 | n/a | n/a | US$73m |
Dec 31 2021 | US$8m | US$870k | US$53m |
Sep 30 2021 | n/a | n/a | US$82m |
Jun 30 2021 | n/a | n/a | US$100m |
Mar 31 2021 | n/a | n/a | US$111m |
Dec 31 2020 | US$7m | US$836k | US$127m |
Sep 30 2020 | n/a | n/a | US$129m |
Jun 30 2020 | n/a | n/a | US$118m |
Mar 31 2020 | n/a | n/a | US$116m |
Dec 31 2019 | US$8m | US$812k | US$113m |
Sep 30 2019 | n/a | n/a | US$106m |
Jun 30 2019 | n/a | n/a | US$105m |
Mar 31 2019 | n/a | n/a | US$103m |
Dec 31 2018 | US$7m | US$724k | US$111m |
Sep 30 2018 | n/a | n/a | US$99m |
Jun 30 2018 | n/a | n/a | US$87m |
Mar 31 2018 | n/a | n/a | US$73m |
Dec 31 2017 | US$6m | US$614k | US$57m |
報酬と市場: Jackの 総報酬 ($USD 13.28M ) は、 US市場 ($USD 5.38M ) の同規模の企業の平均を上回っています。
報酬と収益: Jackの報酬は過去 1 年間で 20% 以上増加しました。
CEO(最高経営責任者
Jack Khattar (63 yo)
19.8yrs
在職期間
US$13,278,093
報酬
Mr. Jack A. Khattar, M.B.A., founded Supernus Pharmaceuticals, Inc. (Formerly, Shire Laboratories, Inc.) in 2005 and has served as Chief Executive Officer, President, Secretary and Director since 2005. He...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Founder | 19.8yrs | US$13.28m | 3.53% $ 70.4m | |
Senior VP & CFO | 3.3yrs | US$2.38m | 0.013% $ 259.7k | |
Chief Scientific Officer & Senior VP of Intellectual Property | 12.7yrs | US$1.47m | 0.018% $ 349.6k | |
Senior Vice President of Quality | 4.8yrs | US$1.79m | 0.015% $ 296.2k | |
Senior VP of Research & Development and Chief Medical Officer | 4.8yrs | US$1.59m | 0.0084% $ 167.5k | |
Compliance Officer | 12.8yrs | データなし | データなし | |
Senior Vice President of Marketing | 9.8yrs | データなし | データなし | |
Senior Vice President of Sales | 9.8yrs | データなし | データなし | |
Senior Vice President of Corporate Development | 9.3yrs | データなし | データなし | |
Senior Vice President of Supply Chain | 3.5yrs | データなし | データなし |
9.6yrs
平均在職期間
63yo
平均年齢
経験豊富な経営陣: SUPNの経営陣は経験豊富で経験豊富です(平均在職期間は9.6年)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Founder | 19.8yrs | US$13.28m | 3.53% $ 70.4m | |
Independent Chairman of the Board | 19.8yrs | US$407.02k | 0.24% $ 4.7m | |
Independent Director | 9.7yrs | US$378.52k | 0.024% $ 480.9k | |
Independent Director | 6.4yrs | US$376.02k | 0.031% $ 621.3k | |
Independent Director | 14.8yrs | US$385.02k | 0.051% $ 1.0m | |
Director | less than a year | US$514.39k | データなし |
12.3yrs
平均在職期間
63.5yo
平均年齢
経験豊富なボード: SUPNの 取締役会 は経験豊富で 経験豊富 です ( 12.3年の平均在任期間)。